OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD4+/CD56+ Hematodermic Tumor
Marco Herling, Dan Jones
American Journal of Clinical Pathology (2007) Vol. 127, Iss. 5, pp. 687-700
Open Access | Times Cited: 177

Showing 26-50 of 177 citing articles:

Blastic plasmacytoid dendritic cell neoplasm: a Swiss case series of a very rare disease and a structured review of the literature
Ramona Meier-Lienhard, Cosima Suter, Thomas Pabst, et al.
Schweizerische medizinische Wochenschrift (2025) Vol. 155, Iss. 1, pp. 3885-3885
Open Access

Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding
Kana Sakamoto, Kengo Takeuchi
Journal of Clinical and Experimental Hematopathology (2025) Vol. 65, Iss. 1, pp. 1-16
Open Access

Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma.
Russell A. Higgins, Jennifer E. Blankenship, Marsha C. Kinney
Archives of Pathology & Laboratory Medicine (2008) Vol. 132, Iss. 3, pp. 441-461
Closed Access | Times Cited: 71

Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis
Xueyan Chen, Sindhu Cherian
Clinics in Laboratory Medicine (2017) Vol. 37, Iss. 4, pp. 753-769
Closed Access | Times Cited: 45

Petechiae and a Persistent Violaceous Nodule: A Presentation of Blastic Plasmacytoid Dendritic Cell Neoplasm to Dermatology
Madison Anzelc, Christina Druskovich, Austin Cusick, et al.
Case Reports in Dermatological Medicine (2025) Vol. 2025, Iss. 1
Open Access

Guidelines for the management of cutaneous lymphomas (2011): A consensus statement by the Japanese Skin Cancer Society – Lymphoma Study Group
Makoto Sugaya, Toshihisa Hamada, Kazuhiro Kawai, et al.
The Journal of Dermatology (2012) Vol. 40, Iss. 1, pp. 2-14
Open Access | Times Cited: 39

An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases
Robert S. Ohgami, Phyu P. Aung, Alejandro A. Gru, et al.
Archives of Pathology & Laboratory Medicine (2022) Vol. 147, Iss. 7, pp. 837-846
Open Access | Times Cited: 17

Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations
Evgenii Shumilov, Paolo Mazzeo, Susanne Ghandili, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1587-1599
Open Access | Times Cited: 3

CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate
Justin J. Leitenberger, Cindy Berthelot, Kristel D. Polder, et al.
Journal of the American Academy of Dermatology (2008) Vol. 58, Iss. 3, pp. 480-484
Closed Access | Times Cited: 43

Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm
Keiko Hashikawa, Daisuke Niino, Shinichiro Yasumoto, et al.
Journal of the American Academy of Dermatology (2011) Vol. 66, Iss. 2, pp. 278-291
Closed Access | Times Cited: 38

Blastic plasmacytoid dendritic cell neoplasm: a single-center experience
Ho Jung An, Dok Hyun Yoon, Shin Kim, et al.
Annals of Hematology (2012) Vol. 92, Iss. 3, pp. 351-356
Closed Access | Times Cited: 33

Histiocytic and Dendritic Cell Neoplasms
Dan Jones
Surgical pathology clinics (2010) Vol. 3, Iss. 4, pp. 1165-1183
Closed Access | Times Cited: 35

Blastic Plasmacytoid Dendritic Cell Neoplasm
Fabio Facchetti
Elsevier eBooks (2011), pp. 788-798
Closed Access | Times Cited: 29

Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study
Marie‐Charlotte Brüggen, Julia Valencak, R. Stranzenbach, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 7, pp. 1489-1495
Open Access | Times Cited: 23

Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm
Tongyuan Xue, Lihua E. Budde
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 575-587
Closed Access | Times Cited: 21

Sequential combination of high dose methotrexate andl-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm
Lila Gilis, Laure Lebras, Fadhéla Bouafia-Sauvy, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2012) Vol. 53, Iss. 8, pp. 1633-1637
Closed Access | Times Cited: 24

Blastic Plasmacytoid Dendritic Cell Neoplasm in the Pediatric Population
Catherine Nguyen, Lauren N. Stuart, Hadas Skupsky, et al.
American Journal of Dermatopathology (2015) Vol. 37, Iss. 12, pp. 924-928
Open Access | Times Cited: 22

Blastic Plasmacytoid Dendritic Cell Neoplasm in Children
Yixian Li, Victoria Sun, Weili Sun, et al.
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 601-612
Closed Access | Times Cited: 20

New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm
Xiang Zhang, Jiewen Sun, Min Yang, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 149, pp. 102928-102928
Closed Access | Times Cited: 19

Natural killer-cell neoplasms
John P. Greer, Claudio A. Mosse
Current Hematologic Malignancy Reports (2009) Vol. 4, Iss. 4, pp. 245-252
Closed Access | Times Cited: 25

A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm
Umberto Falcone, Hassan Sibai, Uday Deotare
Critical Reviews in Oncology/Hematology (2016) Vol. 107, pp. 156-162
Closed Access | Times Cited: 17

Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects
Amy M. Trottier, Sonia Cerquozzi, Carolyn Owen
Blood and Lymphatic Cancer Targets and Therapy (2017) Vol. Volume 7, pp. 85-93
Open Access | Times Cited: 17

Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia
Sarah Bétrian, Sarah Guenounou, Isabelle Luquet, et al.
Hematological Oncology (2015) Vol. 35, Iss. 2, pp. 252-255
Closed Access | Times Cited: 16

Solitary Cutaneous Nodule of Blastic Plasmacytoid Dendritic Cell Neoplasm Progressing to Overt Leukemia Cutis After Chemotherapy: Immunohistology and FISH Analysis Confirmed the Diagnosis
Kjell M. Kaune, Mario Baumgart, Hans Peter Bertsch, et al.
American Journal of Dermatopathology (2009) Vol. 31, Iss. 7, pp. 695-701
Closed Access | Times Cited: 20

Scroll to top